Segment Data

6 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Segment Data

Segment Data

The Company's organizational structure is based upon two principal business segments: BD Medical (“Medical”) and BD Life Sciences (“Life Sciences”). These segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses. As more fully discussed in Note 9, the Company sold a 50.1% controlling financial interest in its Respiratory Solutions business, a component of the Medical segment, in October 2016. This transaction did not meet the criteria established for reporting discontinued operations and as such, results for the three and six months ended March 31, 2016 included $213 million and $421 million, respectively, of revenues which did not occur in the current-year periods.

Financial information for the Company’s segments was as follows:

	Three Months Ended March 31,						Six Months Ended March 31,
(Millions of dollars)	2017			2016			2017			2016
Revenues (A)
Medical	$	1,987		$	2,131		$	3,951		$	4,185
Life Sciences	982			936			1,940			1,869
Total Revenues	$	2,969		$	3,067		$	5,892		$	6,054
Income Before Income Taxes
Medical	$	537		$	513		$	1,085		$	978
Life Sciences	177			202			376			404
Total Segment Operating Income	714			715			1,461			1,381
Acquisitions and other restructurings	(76		)	(104		)	(163		)	(225		)
Net interest expense	(79		)	(96		)	(169		)	(187		)
Other unallocated items (B)	(197		)	(139		)	(76		)	(328		)
Income Before Income Taxes	$	362		$	376		$	1,054		$	642

(A) Intersegment revenues are not material.

(B) Primarily comprised of foreign exchange, corporate expenses, and share-based compensation expense. The amount for the six months ended March 31, 2017 also included a $336 million reversal of certain reserves related to an appellate court decision which, among other things, reversed an unfavorable antitrust judgment in the RTI case. Additional disclosures regarding this legal matter are provided Note 5.

Revenues by geographic areas were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
(Millions of dollars)	2017		2016		2017		2016
Revenues
United States	$	1,627	$	1,719	$	3,257	$	3,410
International	1,342		1,349		2,635		2,644
Total Revenues	$	2,969	$	3,067	$	5,892	$	6,054